Calamine Lotion Rose
Natural health product licensed in Canada
- Other names
- Cell Calamine Lotion Rose
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80100492
- Status
- Active licence
- Licence date
- 21 May 2020
- Revision date
- Not provided
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Oxyde de zinc Source : Oxyde de zinc | 5 % (p/v) |
| Oxyde de zinc Source : Oxyde de zinc | 50 mg/ml |
Non-medicinal ingredients
Citrate de sodium, Extrait de Rosa Damascena, Eau purifiée, Carboxyméthylcellulose de sodium, Glycérol, Phénol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 12 years ; maximum: 17 years | Not specified | Not specified |
| Adultes | minimum: 18 years | Not specified | Not specified |
| Nourrissons | minimum: 6 months ; maximum: 12 months | Not specified | Not specified |
| Enfants | minimum: 1 year ; maximum: 11 years | Not specified | Not specified |
Uses authorised in Canada
Temporarily dries the oozing and weeping and helps relieve minor skin irritation and itching due to poison ivy/oak/sumac.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away. Stop use and ask/consult a doctor/ physician/ health care practitioner/ health care provider/ health care professional if symptoms worsen or last for more than 7 days. When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
- Contre-indications
Do not use on broken skin.
Source
Official Health Canada record, licence 80100492
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.